Custom Premix Selecting "Custom Premix" option means that all of the beads you have chosen will be premixed in manufacturing before the kit is sent to you.
Native very low density lipoproteins from human plasma. VLDL transports liver-synthesized triglycerides and cholesterol. May counteract the inhibitory effect of glucocorticoids on arachidonic acid release and prostaglandin I2 formation in vascular smooth muscle cells. Composition: 88-95% lipid; 5-12% protein.
A 5 mg vial contains ~1 mg of protein.
Catalogue Number
437647
Brand Family
Calbiochem®
Synonyms
VLDL
References
References
Petrichenko, I., et al. 1993. Biochim. Biophys. Acta1166, 183.
≥95% of total lipoprotein content by electrophoresis
Source
Prepared from plasma that has been shown by certified tests to be negative for HBsAg and for antibodies to HIV and HCV.
Concentration Label
Please refer to vial label for lot-specific concentration
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Storage and Shipping Information
Ship Code
Blue Ice Only
Toxicity
Standard Handling
Storage
+2°C to +8°C
Do not freeze
Yes
Special Instructions
This product does not contain preservatives, so it is recommended that it be used under a laminar flow hood. Following initial use, this product is stable for 1 week at 2-8°C.
Petrichenko, I., et al. 1993. Biochim. Biophys. Acta1166, 183.
数据表
Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.
Revision
05-May-2010 JSW
Synonyms
VLDL
Description
Native very low density lipoproteins from human plasma. VLDL transports hepatic synthesized triglycerides and cholesterol. May counteract the inhibitory effect of glucocorticoids on arachidonic acid release and prostaglandin I2 formation in vascular smooth muscle cells. (Composition: 88-95% lipid; 5-12% protein. Note: 5 mg vial contains 1 mg of protein.)
Form
Liquid
Formulation
In 150 mM NaCl, 0.01% EDTA, pH 7.4.
Concentration Label
Please refer to vial label for lot-specific concentration
Source
Prepared from plasma that has been shown by certified tests to be negative for HBsAg and for antibodies to HIV and HCV.
Purity
≥95% of total lipoprotein content by electrophoresis
Storage
+2°C to +8°C
Do Not Freeze
Yes
Special Instructions
This product does not contain preservatives, so it is recommended that it be used under a laminar flow hood. Following initial use, this product is stable for 1 week at 2-8°C.
Toxicity
Standard Handling
References
Petrichenko, I., et al. 1993. Biochim. Biophys. Acta1166, 183.
